Medication prescribing errors in a pediatric inpatient tertiary care setting in Saudi Arabia

Majed I Al-Jeraisy1, Menyfah Q Alanazi, Mostafa A Abolfotouh

  • 1King Abdullah International Medical Research Center, King Saud Bin-Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia. mabolfotouh@gmail.com.

BMC Research Notes
|August 16, 2011
PubMed
Abstract

Insights

Medication errors in pediatric care are frequent, with dose and route errors being most common. This study highlights high error rates in Saudi Arabia, emphasizing the need for further research.

Area of Science:

  • Pediatric pharmacology
  • Patient safety
  • Health services research

Background:

  • Medication errors (MEs) are a leading cause of preventable harm in healthcare.
  • Medication prescribing errors (MPEs) are a significant subset of MEs, particularly in pediatric settings.
  • Understanding the incidence and risk factors for MPEs is crucial for improving pediatric patient safety.

Purpose of the Study:

  • To determine the incidence and types of medication prescribing errors (MPEs) in a Saudi Arabian pediatric tertiary care setting.
  • To identify potential risk factors associated with MPEs in this population.
  • To provide data for interventions aimed at reducing pediatric medication errors.

Main Methods:

  • A retrospective cohort study was conducted over five weeks.
  • Physician medication orders and patient files were reviewed in general pediatric and pediatric intensive care units (PICU).
  • A total of 2,380 medication orders were analyzed to identify MPEs and their characteristics.

Main Results:

  • The overall MPE rate was 56 per 100 medication orders.
  • Dose errors (22.1%) were the most prevalent type, followed by route (12.0%) and clarity errors (11.4%).
  • High error rates were observed for electrolytes, antibiotics, and bronchodilators, with significant occurrences in the PICU.

Conclusions:

  • The incidence of medication prescribing errors in this Saudi pediatric setting is significantly high.
  • Further large-scale prospective studies are recommended to fully ascertain the extent and impact of pediatric medication errors.
  • Findings underscore the need for targeted interventions to enhance medication safety in pediatric care.

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...